Logo image of ZK

ZEEKR INTELLIGENT TECHNO-ADR (ZK) Stock Fundamental Analysis

NYSE:ZK - US98923K1034 - ADR

29.46 USD
-0.4 (-1.34%)
Last: 8/27/2025, 4:10:02 PM
29.46 USD
0 (0%)
After Hours: 8/27/2025, 4:10:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ZK. ZK was compared to 37 industry peers in the Automobiles industry. Both the profitability and financial health of ZK have multiple concerns. ZK is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ZK had negative earnings in the past year.
ZK Yearly Net Income VS EBIT VS OCF VS FCFZK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2B -2B -4B -6B -8B

1.2 Ratios

Looking at the Return On Assets, with a value of -8.39%, ZK is in line with its industry, outperforming 56.76% of the companies in the same industry.
Industry RankSector Rank
ROA -8.39%
ROE N/A
ROIC N/A
ROA(3y)-30.39%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZK Yearly ROA, ROE, ROICZK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

With a decent Gross Margin value of 17.94%, ZK is doing good in the industry, outperforming 72.97% of the companies in the same industry.
ZK's Gross Margin has been stable in the last couple of years.
ZK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5YN/A
ZK Yearly Profit, Operating, Gross MarginsZK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

ZK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZK has been increased compared to 1 year ago.
Compared to 1 year ago, ZK has a worse debt to assets ratio.
ZK Yearly Shares OutstandingZK Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 50M 100M 150M 200M 250M
ZK Yearly Total Debt VS Total AssetsZK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.07, we must say that ZK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.07, ZK perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.07
ROIC/WACCN/A
WACC6.3%
ZK Yearly LT Debt VS Equity VS FCFZK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5B -5B -10B

2.3 Liquidity

ZK has a Current Ratio of 0.59. This is a bad value and indicates that ZK is not financially healthy enough and could expect problems in meeting its short term obligations.
ZK has a Current ratio of 0.59. This is in the lower half of the industry: ZK underperforms 72.97% of its industry peers.
A Quick Ratio of 0.45 indicates that ZK may have some problems paying its short term obligations.
The Quick ratio of ZK (0.45) is worse than 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.45
ZK Yearly Current Assets VS Current LiabilitesZK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

7

3. Growth

3.1 Past

ZK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.99%, which is quite good.
Looking at the last year, ZK shows a very strong growth in Revenue. The Revenue has grown by 46.91%.
Measured over the past years, ZK shows a very strong growth in Revenue. The Revenue has been growing by 126.56% on average per year.
EPS 1Y (TTM)18.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.87%
Revenue 1Y (TTM)46.91%
Revenue growth 3Y126.56%
Revenue growth 5YN/A
Sales Q2Q%37.55%

3.2 Future

Based on estimates for the next years, ZK will show a very strong growth in Earnings Per Share. The EPS will grow by 41.56% on average per year.
The Revenue is expected to grow by 38.00% on average over the next years. This is a very strong growth
EPS Next Y47.79%
EPS Next 2Y49.02%
EPS Next 3Y41.56%
EPS Next 5YN/A
Revenue Next Year52.57%
Revenue Next 2Y40.57%
Revenue Next 3Y38%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ZK Yearly Revenue VS EstimatesZK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
ZK Yearly EPS VS EstimatesZK Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 1 -1 2 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ZK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 305.08 indicates a quite expensive valuation of ZK.
Based on the Price/Forward Earnings ratio, ZK is valued a bit cheaper than the industry average as 62.16% of the companies are valued more expensively.
ZK is valuated expensively when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 305.08
ZK Price Earnings VS Forward Price EarningsZK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZK Per share dataZK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ZK's earnings are expected to grow with 41.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.02%
EPS Next 3Y41.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEEKR INTELLIGENT TECHNO-ADR

NYSE:ZK (8/27/2025, 4:10:02 PM)

After market: 29.46 0 (0%)

29.46

-0.4 (-1.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-14 2025-11-14
Inst Owners4.72%
Inst Owner Change8.44%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.55B
Analysts84.62
Price Target35.88 (21.79%)
Short Float %0.25%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-675.27%
Min EPS beat(2)-1188.89%
Max EPS beat(2)-161.65%
EPS beat(4)2
Avg EPS beat(4)-310.25%
Min EPS beat(4)-1188.89%
Max EPS beat(4)62%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.25%
Min Revenue beat(2)-4.51%
Max Revenue beat(2)15.01%
Revenue beat(4)3
Avg Revenue beat(4)6.84%
Min Revenue beat(4)-4.51%
Max Revenue beat(4)15.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-159.96%
EPS NY rev (1m)35.24%
EPS NY rev (3m)-6.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.11%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)-4.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 305.08
P/S 0.65
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)0.1
Fwd EY0.33%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS45.37
BVpS-12.91
TBVpS-13.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.94%
FCFM N/A
ROA(3y)-30.39%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.45
Altman-Z 0.07
F-ScoreN/A
WACC6.3%
ROIC/WACCN/A
Cap/Depr(3y)291.47%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.87%
EPS Next Y47.79%
EPS Next 2Y49.02%
EPS Next 3Y41.56%
EPS Next 5YN/A
Revenue 1Y (TTM)46.91%
Revenue growth 3Y126.56%
Revenue growth 5YN/A
Sales Q2Q%37.55%
Revenue Next Year52.57%
Revenue Next 2Y40.57%
Revenue Next 3Y38%
Revenue Next 5YN/A
EBIT growth 1Y25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.32%
EBIT Next 3Y58.35%
EBIT Next 5YN/A
FCF growth 1Y312.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.62%
OCF growth 3Y71.86%
OCF growth 5YN/A